Literature DB >> 10663751

MRI of bone marrow disorders.

D Vanel1, C Dromain, A Tardivon.   

Abstract

Four factors can be used in MR of bone marrow: fat-water distribution, artifacts induced by bone trabeculae, diffusion, and uptake of contrast media. Fat-water is imaged using T1-weighted spin-echo, short tau inversion recovery (STIR), and fast STIR, in- and out-of-phase gradient echo, and fat pre-saturation sequences; bone trabeculae by gradient echo with long TE; diffusion by single-shot spin-echo. The injection of contrast media is a more easy and efficient way to improve the specificity. The value and limitations of those sequences are discussed in marrow replacements (metastases, lymphoma, leukemia) and in myeloid hyperplasia or depletion.

Entities:  

Mesh:

Year:  2000        PMID: 10663751     DOI: 10.1007/s003300050038

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  18 in total

Review 1.  Magnetic resonance imaging of the spinal marrow: Basic understanding of the normal marrow pattern and its variant.

Authors:  Mohamed Ragab Nouh; Ahmed Fathi Eid
Journal:  World J Radiol       Date:  2015-12-28

Review 2.  The evolving role of MRI in oncohaematological disorders.

Authors:  O Tamburrini; M A Cova; D Console; P Martingano
Journal:  Radiol Med       Date:  2007-07-24       Impact factor: 3.469

Review 3.  Magnetic resonance imaging of bone marrow in oncology, Part 1.

Authors:  Sinchun Hwang; David M Panicek
Journal:  Skeletal Radiol       Date:  2007-05-11       Impact factor: 2.199

4.  Rapid bone destruction in a patient with knee osteoarthritis. A case report and review of the literature.

Authors:  Masatoshi Komatsu; Mikio Kamimura; Yukio Nakamura; Keijiro Mukaiyama; Shota Ikegami; Shigeharu Uchiyama; Hiroyuki Kato
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

5.  MRI versus 18F-FDG-PET/CT for detecting bone marrow involvement in multiple myeloma: diagnostic performance and clinical relevance.

Authors:  Frédéric E Lecouvet; Dimitar Boyadzhiev; Laurence Collette; Maude Berckmans; Nicolas Michoux; Perrine Triqueneaux; Vassiliki Pasoglou; François Jamar; Marie-Christiane Vekemans
Journal:  Eur Radiol       Date:  2019-12-16       Impact factor: 5.315

6.  Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.

Authors:  Ahmed Larbi; Patrick Omoumi; Vassiliki Pasoglou; Nicolas Michoux; Perrine Triqueneaux; Bertrand Tombal; Catherine Cyteval; Frédéric E Lecouvet
Journal:  Eur Radiol       Date:  2018-11-09       Impact factor: 5.315

7.  Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT.

Authors:  Gerwin P Schmidt; Stefan O Schoenberg; Rupert Schmid; Robert Stahl; Reinhold Tiling; Christoph R Becker; Maximilian F Reiser; Andrea Baur-Melnyk
Journal:  Eur Radiol       Date:  2006-09-02       Impact factor: 5.315

8.  The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan.

Authors:  Nishikant Avinash Damle; Chandrasekhar Bal; G P Bandopadhyaya; Lalit Kumar; Praveen Kumar; Arun Malhotra; Sneh Lata
Journal:  Jpn J Radiol       Date:  2013-02-02       Impact factor: 2.374

9.  Imaging of primary bone tumors: determination of tumor extent by non-contrast sequences.

Authors:  Ney Tatizawa Shiga; Filippo Del Grande; Olivia Lardo; Laura M Fayad
Journal:  Pediatr Radiol       Date:  2013-01-23

Review 10.  Diffusion-weighted imaging of bone marrow: current status.

Authors:  Andrea Baur; Olaf Dietrich; Maximilian Reiser
Journal:  Eur Radiol       Date:  2003-05-21       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.